Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL)
Tweet Send to a Friend
Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating and $42.00 price target on Castle Biosciences (NASDAQ: CSTL).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
